Boceprevir

Merck Girds For Hep C Battle With Roche Deal

Merck Girds For Hep C Battle With Roche Deal

TheStreet.com

Merck's FDA Win Bodes Well for Vertex

Merck's FDA Win Bodes Well for Vertex

Minyanville

The Merck Hepatitis C Med: What The Wags Say

The Merck Hepatitis C Med: What The Wags Say

Pharmalot

FDA panel gives nod to Merck hep C drug Read more: FDA panel gives nod to Merck hep C drug | Philadelphia Business Journal

FDA panel gives nod to Merck hep C drug

Bizjournals.com

Merck: FDA Hep C Panel Live Blog

Merck: FDA Hep C Panel Live Blog

TheStreet.com

Vertex, Merck Step Up to the Public Stage With Hepatitis C Drugs This Week

Vertex, Merck Step Up to the Public Stage With Hepatitis C Drugs This Week

Motley Fool

FDA says highly anticipated Merck drug achieved goal of eliminating traces of hepatitis C

FDA says highly anticipated Merck drug achieved goal of eliminating traces of hepatitis C

Yahoo/AP

Merck, Vertex Prep for Hep C Drug Panels

Merck, Vertex Prep for Hep C Drug Panels

TheStreet.com

Merck, J&J’s New Hepatitis C Treatments Fetch $31,000 in France

Merck, J&J’s New Hepatitis C Treatments Fetch $31,000 in France

Bloomberg

News

Merck's Investigational Medicine Boceprevir Achieved Significantly Higher SVR Rates In Treatment-Failure and Treatment-Naïve Adult Patients with Chronic Hepatitis C Genotype 1 Compared to Control

Yahoo/BusinessWire